tiprankstipranks
Trending News
More News >
OptimizeRx Corporation (OPRX)
NASDAQ:OPRX
US Market

OptimizeRx (OPRX) Financial Statements

Compare
488 Followers

OptimizeRx Financial Overview

OptimizeRx's market cap is currently $143.30M. The company's EPS TTM is $-1.101; its P/E ratio is ―; OptimizeRx is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 92.13M$ 71.52M$ 62.45M$ 61.29M$ 43.31M
Gross Profit$ 59.38M$ 42.90M$ 38.97M$ 35.64M$ 24.11M
Operating Income$ -13.71M$ -26.40M$ -12.29M$ 482.23K$ -1.89M
EBITDA$ -8.90M$ -21.31M$ -9.42M$ 2.33M$ -59.43K
Net Income$ -20.11M$ -17.57M$ -10.59M$ 273.93K$ -2.38M
Balance Sheet
Cash & Short-Term Investments$ 13.38M$ 13.85M$ 74.14M$ 84.68M$ 10.52M
Total Assets$ 171.17M$ 183.37M$ 134.65M$ 140.99M$ 60.33M
Total Debt$ 2.38M$ 36.82M$ 234.43K$ 327.71K$ 448.75K
Net Debt$ -11.00M$ 22.97M$ -17.97M$ -84.35M$ -10.07M
Total Liabilities$ 54.17M$ 56.82M$ 8.54M$ 9.61M$ 10.35M
Stockholders' Equity$ 117.00M$ 126.55M$ 126.11M$ 131.38M$ 49.97M
Cash Flow
Free Cash Flow$ 4.78M$ -8.11M$ 10.41M$ 240.04K$ -6.44M
Operating Cash Flow$ 4.89M$ -7.24M$ 10.65M$ 726.04K$ -6.31M
Investing Cash Flow$ -450.00K$ -25.34M$ -58.18M$ -486.00K$ -124.72K
Financing Cash Flow$ -4.91M$ 28.22M$ -18.95M$ 73.92M$ -1.90M
Currency in USD

OptimizeRx Earnings and Revenue History

OptimizeRx Debt to Assets

OptimizeRx Cash Flow

OptimizeRx Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis